CYTEK BIOSCIENCES, INC. (CTKB) Net margin 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) net profit margin by fiscal year — reported net income divided by reported revenue.
-33.0%FY2025 · since FY2020: 20.9% → -33.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -33.0% | -30.0 pp |
| FY2024 | -3.0% | +3.3 pp |
| FY2023 | -6.3% | -7.8 pp |
| FY2022 | 1.5% | -0.9 pp |
| FY2021 | 2.4% | -18.5 pp |
| FY2020 | 20.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Gross profitCTKB Gross marginCTKB Operating incomeCTKB Operating marginCTKB Operating cash flowCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →